EP2297332A4 - Procédés et plateformes pour la découverte de médicaments - Google Patents

Procédés et plateformes pour la découverte de médicaments

Info

Publication number
EP2297332A4
EP2297332A4 EP09763772A EP09763772A EP2297332A4 EP 2297332 A4 EP2297332 A4 EP 2297332A4 EP 09763772 A EP09763772 A EP 09763772A EP 09763772 A EP09763772 A EP 09763772A EP 2297332 A4 EP2297332 A4 EP 2297332A4
Authority
EP
European Patent Office
Prior art keywords
discovering
medicines
platforms
methods
discovering medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09763772A
Other languages
German (de)
English (en)
Other versions
EP2297332A2 (fr
Inventor
Kazuhiro Sakurada
Kenneth J Seidenman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto University NUC
Original Assignee
Kyoto University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto University NUC filed Critical Kyoto University NUC
Publication of EP2297332A2 publication Critical patent/EP2297332A2/fr
Publication of EP2297332A4 publication Critical patent/EP2297332A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP09763772A 2008-06-13 2009-06-12 Procédés et plateformes pour la découverte de médicaments Withdrawn EP2297332A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6159408P 2008-06-13 2008-06-13
US6159208P 2008-06-13 2008-06-13
PCT/US2009/047291 WO2009152484A2 (fr) 2008-06-13 2009-06-12 Procédés et plateformes pour la découverte de médicaments

Publications (2)

Publication Number Publication Date
EP2297332A2 EP2297332A2 (fr) 2011-03-23
EP2297332A4 true EP2297332A4 (fr) 2012-03-21

Family

ID=41417418

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09763772A Withdrawn EP2297332A4 (fr) 2008-06-13 2009-06-12 Procédés et plateformes pour la découverte de médicaments

Country Status (3)

Country Link
EP (1) EP2297332A4 (fr)
CN (1) CN102203275A (fr)
WO (2) WO2009152485A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005849A1 (fr) * 2009-07-08 2011-01-13 Cellular Dynamics International, Inc. Cellules ips modifiées ayant une forme mutante du gène d’entrée cellulaire du virus d’immunodéficience humaine (vih)
WO2011119942A1 (fr) * 2010-03-25 2011-09-29 Vistagen Therapeutics, Inc. Induction de cellules ips en utilisant des vecteurs épisomiques transitoires
EP2563907B1 (fr) 2010-04-28 2019-06-19 The J. David Gladstone Institutes Procédés de génération de cardiomyocytes
US9228204B2 (en) 2011-02-14 2016-01-05 University Of Utah Research Foundation Constructs for making induced pluripotent stem cells
WO2012116111A1 (fr) * 2011-02-22 2012-08-30 Sanford-Burnham Medical Research Institute Méthode et composés pour générer des ipsc
JP6298405B2 (ja) 2011-08-30 2018-03-20 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ 心筋細胞を生成するための方法
JP2018537118A (ja) * 2015-10-05 2018-12-20 オリジェン， インコーポレイテッド 肝機能不全の同定および緩和に基づくパーキンソン病の診断および処置
CN107603951B (zh) * 2016-07-12 2020-08-14 中国人民解放军军事医学科学院基础医学研究所 一种用于在体诱导成熟神经元分裂的新型生长/神经营养因子组合物及其用途
GB201708554D0 (en) * 2017-05-30 2017-07-12 Queens Univ Of Belfast A method for the generation of induced pluirpotent stem cells
GB2583309A (en) * 2017-12-28 2020-10-21 Ibm Neuron model generation for personalised drug treatment
US11227692B2 (en) * 2017-12-28 2022-01-18 International Business Machines Corporation Neuron model simulation
CN109294975A (zh) * 2018-10-23 2019-02-01 山东华思生物科技有限公司 一种干细胞药物筛选方法
US20220028488A1 (en) * 2018-12-07 2022-01-27 President And Fellows Of Harvard College Drug discovery and early disease identification platform using electronic health records, genetics and stem cells
US20220076839A1 (en) * 2018-12-21 2022-03-10 I Peace, Inc. Health risk information management device, health risk information management method, and program
CN111621546A (zh) * 2020-06-18 2020-09-04 上海诚益生物科技有限公司 一种利用原代肝细胞筛选甲状腺素受体激动剂的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222636A1 (en) * 2003-09-19 2006-10-05 The Rockefeller University Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
WO2009061442A1 (fr) * 2007-11-06 2009-05-14 Children's Medical Center Corporation Procédé de production de cellules souches pluripotentes induites (ips) à partir de cellules humaines non embryonnaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010536A1 (fr) * 1997-08-22 1999-03-04 Yale University Procede d'etude des modifications de l'expression des genes dans les granulocytes
US20040048297A1 (en) * 2002-07-30 2004-03-11 Gene Logic, Inc. Nucleic acid detection assay control genes
US20070184030A1 (en) * 2004-03-03 2007-08-09 Cryo-Save Ag (Formerly Life Sciences Ag) Large scale storage of viable somatic stem and/or progenitor cells
EP1738253A4 (fr) * 2004-03-26 2009-07-22 Celgene Corp Systemes et procedes pour produire une banque de cellules souches
CA2630708C (fr) * 2007-09-13 2017-08-01 Clifford L. Librach Methode d'isolement et d'utilisation de cellules formees a partir de tissus foetaux du cordon ombilical preleves au premier trimestre de la grossesse

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222636A1 (en) * 2003-09-19 2006-10-05 The Rockefeller University Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
WO2009061442A1 (fr) * 2007-11-06 2009-05-14 Children's Medical Center Corporation Procédé de production de cellules souches pluripotentes induites (ips) à partir de cellules humaines non embryonnaires

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EBERT ALLISON D ET AL: "Induced pluripotent stem cells from a spinal muscular atrophy patient", NATURE 15 JAN 2009,, vol. 457, no. 7227, 15 January 2009 (2009-01-15), pages 277 - 280, XP002552498, DOI: 10.1038/NATURE07677 *
MALI PRASHANT ET AL: "Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts", STEM CELLS (MIAMISBURG), vol. 26, no. 8, 29 May 2008 (2008-05-29), pages 1998 - 2005, XP002668773, ISSN: 1066-5099 *

Also Published As

Publication number Publication date
WO2009152485A3 (fr) 2010-05-14
CN102203275A (zh) 2011-09-28
WO2009152484A2 (fr) 2009-12-17
WO2009152485A2 (fr) 2009-12-17
EP2297332A2 (fr) 2011-03-23
WO2009152484A3 (fr) 2010-03-11

Similar Documents

Publication Publication Date Title
EP2297332A4 (fr) Procédés et plateformes pour la découverte de médicaments
IL287311A (en) Antibodies and processes for preparing the same
EP2373413A4 (fr) Catalyseurs et procédés de déparaffinage
EP2358669A4 (fr) Alpha-céto-peracides et procédés pour produire et utiliser ceux-ci
EP2217371A4 (fr) Catalyseurs et procédés apparentés
EP2046996A4 (fr) Procédés pour la sélection des médicaments
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
EP1981512A4 (fr) Macromolecule modifiee
BRPI0720886A2 (pt) Recipiente
EP2297645A4 (fr) Plateforme de messagerie étendue
BRPI0912173A2 (pt) anticorpos anti-flt3
IL212175B (en) Muc1* antibodies
BRPI0920903A2 (pt) aparelho de empacotamento
BRPI0809978A2 (pt) Dispositivos e métodos de dispensação de gotículas
BRPI0910723A2 (pt) aparelho e método de frenagem.
DE602007011183D1 (de) Hydrazinfunktionalisiertes Polymer
BRPI0721469A2 (pt) Plataforma autoelevatória
BRPI0914274A2 (pt) plataforma
DE502007005526D1 (de) Pipettiervorrichtung
SE0801651L (sv) Granuleringskvarn
BRPI0914151A2 (pt) distribuidor de medicamento e método
JP2008297558A5 (ja) 重合方法
ATE475602T1 (de) AUSGIEßER
DE112007002097A5 (de) Antriebsstrang
EP2252246A4 (fr) Procédés et compositions pour la chimioprotection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110111

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KYOTO UNIVERSITY

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120221

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/15 20060101ALI20120213BHEP

Ipc: C12Q 1/02 20060101AFI20120213BHEP

17Q First examination report despatched

Effective date: 20130424

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140924